How are new MS medicines approved?

Medicines pills tablets
Photo by Pixabay on

If you have MS or any other chronic or acute illness, you might be dependent on pharmaceutical intervention at some stage.

But, how exactly do your medicines arrive in your hands once they passed the clinical trials stage?

The EMA (European Medicines Agency) own scientific committees will scientifically assess the clinical trial data. Once this stage is finished, the EMA gives independent recommendations on medicines. When they receive a green light, i.e. when the benefit of the medicine is greater than its risk, the EMA gives its approval to the EC, the European Commission. This means it can be authorised and can now be marketed across the European Union, including the EEC, the European Economic Area.

It doesn’t end there, however. The EMA will continue to monitor the safety of the medicine when it’s on the market.

More info:

⬛ Authorisation of medicines

⬛ Committees, working parties and other groups

⬛ Committee for Medicinal Products for Human Use (CHMP)

⬛ Committee for Orphan Medicinal Products (COMP)

⬛ Committee on Herbal Medicinal Products (HMPC)

⬛ Committee for Advanced Therapies (CAT)

⬛ EU institutions and bodies in brief

More on medicines on IMSM:

⬛ MS Treatments (2018)

⬛ Disease Modifying Therapies for Multiple Sclerosis: A Review of the Perspectives of Irish People with MS

⬛ Understanding clinical trials

While you’re here, why not check out these pages?

UPDATED: August 17th, 2018


Winner Best Blog Post 2018 Ireland Blog Awards

2018 Winner Best Blog Post with ‘3443 Needles’, Blog Awards Ireland, Ashville Media Group, Dublin, Ireland

◾ Ireland Blog Awards Finalist 2014, 2015, 2017
◾ MyTherapyApp Best MS Blog for Simplicity 2018
◾ Everyday Health Top 10 MS Blog of 2018
◾ Feedspot Top 50 MS Blog 2017, 2018

© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and with appropriate and specific direction to the original content.

One thought on “How are new MS medicines approved?

  1. Good morning dear Blue-eyes and thanks for this good article about the approval process of new medicines in the EU. However you should point out that the system is under duress now as the headquarters is located in the UK, which will leave the EU in the near future. They are discussing where to relocate now and I do hope they chose a “serious” place like Barcelona or Prague to continue their exacting and necessary watchdog role. Un baccione. Arrivederci!

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.